​

Champions Oncology Ownership | Who Owns Champions Oncology?


OverviewForecastRevenueFinancialsChartTranscripts

Champions Oncology Ownership Summary


Champions Oncology is owned by 42.58% institutional investors, 26.33% insiders, and 31.09% retail investors. Battery management is the largest institutional shareholder, holding 17.44% of CSBR shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 1.70% of its assets in Champions Oncology shares.

CSBR Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockChampions Oncology42.58%26.33%31.09%
SectorHealthcare Stocks 247.07%12.15%-159.22%
IndustryBiotech Stocks 385.89%11.79%-297.68%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Battery management2.42M17.44%$13.92M
Nea management company1.71M12.34%$9.85M
Vanguard group334.61K2.43%$2.31M
Vanguard capital management301.35K2.17%$1.51M
Tocqueville asset management295.66K2.13%$1.48M
Morgan stanley195.60K1.41%$978.00K
Renaissance129.64K0.93%$648.20K
Blackrock funding, inc. /de128.54K0.92%$642.70K
Blackrock116.07K0.85%$600.09K
Mink brook asset management111.34K0.80%$556.69K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Battery management2.42M3.27%$13.92M
Nea management company1.71M0.56%$9.85M
Mink brook asset management111.34K0.26%$556.69K
Tocqueville asset management295.66K0.02%$1.48M
Mesirow financial investment management15.80K0.00%$79.00K
Renaissance129.64K0.00%$648.20K
Hightower advisors41.90K0.00%$209.50K
Morgan stanley195.60K0.00%$978.00K
Acadian asset management20.52K0.00%$102.00K
Cambridge investment research advisors12.25K0.00%$61.00K

Top Buyers

HolderShares% AssetsChange
Susquehanna group, llp11.52K-11.52K
Vanguard fiduciary trust40.68K-7.44K
Simplex trading3.00K-1.41K
Lazard asset management1.35K-1.35K
Vanguard group334.61K-1.35K

Top Sellers

HolderShares% AssetsChange
Eam investors---79.99K
Goldman sachs group---48.41K
Morgan stanley195.60K0.00%-39.80K
Hillsdale investment management---25.10K
Dimensional fund advisors lp---23.97K

New Positions

HolderShares% AssetsChangeValue
Susquehanna group, llp11.52K-11.52K$98.76K
Lazard asset management1.35K-1.35K$9.00K
Nuveen101.00-101.00$484.00

Sold Out

HolderChange
Fmr-1.00
Wells fargo & company/mn-47.00
Advisor group-100.00
Ubs group-190.00
Tower research capital llc (trc)-501.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 2026278.00%5,889,2522.74%422.48%9-7-
Mar 31, 202619-29.63%1,229,382-78.62%80.51%7-36.36%6-14.29%
Dec 31, 202523-11.54%1,583,092-72.05%110.68%1042.86%6-33.33%
Sep 30, 202526-18.75%5,663,057-1.90%412.33%7-46.15%928.57%
Jun 30, 202532-11.11%5,772,831-2.44%412.25%13-35.00%716.67%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard US Total Market Shares ETF235.74K1.70%-
Vanguard Total Stock Mkt Idx Inv229.97K1.66%-
Vanguard Morn Total Stk Mkt Idx Investor229.97K1.66%-
Vanguard MStar Total Stk Mkt Idx Invest229.97K1.65%-
IMC US Ultra Micro Cap88.31K0.64%-
Vanguard Institutional Extnd Mkt Idx Tr62.77K0.45%-
Pleiades Small Cap Equity A44.16K0.32%44.16K
Fidelity Extended Market Index30.94K0.22%-116.00
iShares Micro-Cap ETF25.84K0.19%-
Blackrock Extended Mkt Fund CF12.81K0.09%-

Recent Insider Transactions


DateNameRoleActivityValue
Jan 12, 2024Mendelson Daniel Newman-Buy$6.50K
Jan 11, 2024Mendelson Daniel Newman-Buy$12.54K
Jan 10, 2024Mendelson Daniel Newman-Buy$18.58K
Jan 09, 2024Mendelson Daniel Newman-Buy$18.75K
Jan 08, 2024Mendelson Daniel Newman-Buy$6.15K

Insider Transactions Trends


DateBuySell
2026 Q4--
2025 Q4--
2025 Q1--
2024 Q4--
2024 Q18-

CSBR Ownership FAQ


Who Owns Champions Oncology?

Champions Oncology shareholders are primarily institutional investors at 42.58%, followed by 26.33% insiders and 31.09% retail investors. The average institutional ownership in Champions Oncology's industry, Biotech Stocks , is 385.89%, which Champions Oncology falls below.

Who owns the most shares of Champions Oncology?

Champions Oncology’s largest shareholders are Battery management (2.42M shares, 17.44%), Nea management company (1.71M shares, 12.34%), and Vanguard group (334.6K shares, 2.43%). Together, they hold 32.21% of Champions Oncology’s total shares outstanding.

Does Blackrock own Champions Oncology?

Yes, BlackRock owns 0.85% of Champions Oncology, totaling 116.07K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 600.09K$. In the last quarter, BlackRock increased its holdings by 389 shares, a 0.34% change.

Who is Champions Oncology’s biggest shareholder by percentage of total assets invested?

Battery management is Champions Oncology’s biggest shareholder by percentage of total assets invested, with 3.27% of its assets in 2.42M Champions Oncology shares, valued at 13.92M$.

Who is the top mutual fund holder of Champions Oncology shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Champions Oncology shares, with 1.70% of its total shares outstanding invested in 235.74K Champions Oncology shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools